If they're so interested in pursuing this, then they should personally finance it, instead of wasting more tax revenue on another insignificant investigation.
The problem is that Nokia, Samsung, Motorola, and Ericcson spend billions of USD annually on research that has contributed to the underlying technology that makes mobile phones work. Apple hasn't and has little to offer in a cross-licence agreement, since most of their mobile patent holdings consist of weak software patents--many of which probably wouldn't hold up under reexamination. I can imagine why the negotiations have failed, but I've also wondered if the FRAND licenses held by component manufacturers like Qualcomm extend to Apple.
You've touched on the whole point of this without realizing it. Expanding the nexus program will give people more options for unlocked stock Android devices that are updated frequently. I'm not predicting success, but it holds potential.
I'm not sure how HIPAA relates to a university email system, but it's taken pretty seriously in healthcare. HIPPA goes beyond technical requirements; it mandates policies and procedures to be in place to prevent inappropriate disclosure of PHI. The healthcare system that I work at prohibits patient identifying information from being copied or transcribed from the EMR. This includes email, thumb drives, grand rounds, competencies and education, and research. Penalties are severe, including termination and possible action by the state against individuals.
If you're rooted, there are apps on the market that allow you to manage permissions. Cyanogenmod includes this capability in the ROM itself. It would be a nice feature for stock Android to have, but I doubt that will happen.
Does anyone actually know what his training or education background is? I don't think there was never any doubt that he was paid to slander open source software, but I've always wondered if he was one person or an outfit of people, and why he was so often quoted as an "expert" and "consultant" in software patent disputes. Is he a licensed attorney or software engineer, or just a journalist with an interest in this stuff?
Google Earth does not use wine--I don't recall that ever being the case. Download it for yourself and you'll find native linux binaries and libraries with a Qt UI. In fact, Picassa is the only Google product I know of that relies on wine.
In CT, we have the highest state tax on gasoline and among the highest in tax per capita. We probably have the most underfunded state pension fund in the country. The state enacted a tax credit last year that it can't afford, and is being blamed, in part, for the budget deficit we now have. CT has had a spending problem for years, and the answer isn't raising taxes.
This isn't necessarily true. In CT for example, I can't legally prescribe narcotic analgesics to treat heroin dependency. I can prescribe them for pain, but the patient must be in a treatment program and under the care of a physician registered for this purpose. In all other cases, when if I prescribe something off-label, I can incur liability if that patient is harmed from that medication. Lawyers will usually pursue the physician instead or in addition to the manufacturer.
No, toxicology studies are far less costly than clinical trials, which determine if a medication or medical device is efficacious. To gain a new indication on a drug, new clinical trials have to be performed to establish efficacy. Even a single study involving a few thousand patients is incredibly expensive. Also, Proscar is a 5mg dose, not 4mg.
What version of HTML5 will Microsoft support? I thought independent HTML5 benchmarks had IE as the least compatible browser. Are we going back down this road again?
The vast majority of prescribed antipsychotics are atypicals. While they are FDA approved for schizophrenia and type I bipolar, they are also useful off-label in treating major depressive disorder, augmentation in dementia, and even for sleep disorders. The same is true of antidepressants. Tricyclics are often used to treat neuropathic disorders--usually pain, and SSRI's are used off-label for bulimia, Raynaud's, and fibromyalgia. Psychiatric medicine is perhaps the least understood of all areas of medicine. Increased utilization of medication doesn't necessarily correlate with an increase in incidence of disease or inappropriate management of therapy. Historically, this has been linked to improvements in diagnosis rates, and sometimes because the use of a medication has expanded.
I was an intern in the pharmaceutical industry and it gave me a perspective of how shady and deceitful of a business it is. However, it's one example of patents working as intended. Manufacturers can obtain patents on a drug, a novel delivery system, or a device. This doesn't impair other manufacturers from altering the molecule to produce a competing drug. That's why we have drug classes, and often the analogs differ from the progenitor by a single substitution. Consider the statins, a class of antihyperlipidemics and some of the most common drugs used in the US. The newer agents have trended towards improved potency and adverse effect profile, longer half-life, and reduced drug-drug interactions. The patents, applied for during the development phase, typically only have 5-10 years left once the drug is available on the US market, and at that point, vastly less expensive generics can be produced. Thus, patents allow drug manufacturers to recoup the cost of drug development, make a lucrative profit, while fostering innovation and encouraging the production of improved medicines. Good pharmaceuticals never reach obsolescence either; many of the more commonly prescribed meds used today were developed in the 60's, 70's, and 80's.
The XBox is the reason that I think Microsoft has a slim chance at the smartphone market. How many companies can spend billions of US dollars on hardware subsidies over a period of years? We could see 'buy one, get one' deals for a long time to come. Or perhaps a free Windows smartphone with the purchase of a Windows laptop. Unlike Android handset manufacturers and Apple, Microsoft doesn't have to make a profit on WP7. They can lose money hand over fist, but if they are slowly increasing their marketshare, then Microsoft can declare success.
I remember reading that Microsoft paid Nokia 1B USD to make wp7 the primary platform, but not the exclusive one. If this is true, Nokia can continue Meego and low end Symbian, and dabble in Android if necessary without breaking the deal they made. They might have to.
The report sort of becomes a sales pitch halfway through:
OpenLogic sells a product called the OLEX App Store Edition which provides tooling that can be used by developers to do a self-service scan on their apps prior to submitting to the app store and by app stores to track open source compliance.
I don't doubt that violations are occurring, but I question data when not provided by an independent third party.
Slashdot Mirror
Live by the sword, die by the sword.
It also uses a OMAP4 chip, which seems like overkill for a media player.
If they're so interested in pursuing this, then they should personally finance it, instead of wasting more tax revenue on another insignificant investigation.
The problem is that Nokia, Samsung, Motorola, and Ericcson spend billions of USD annually on research that has contributed to the underlying technology that makes mobile phones work. Apple hasn't and has little to offer in a cross-licence agreement, since most of their mobile patent holdings consist of weak software patents--many of which probably wouldn't hold up under reexamination. I can imagine why the negotiations have failed, but I've also wondered if the FRAND licenses held by component manufacturers like Qualcomm extend to Apple.
You've touched on the whole point of this without realizing it. Expanding the nexus program will give people more options for unlocked stock Android devices that are updated frequently. I'm not predicting success, but it holds potential.
I'm not sure how HIPAA relates to a university email system, but it's taken pretty seriously in healthcare. HIPPA goes beyond technical requirements; it mandates policies and procedures to be in place to prevent inappropriate disclosure of PHI. The healthcare system that I work at prohibits patient identifying information from being copied or transcribed from the EMR. This includes email, thumb drives, grand rounds, competencies and education, and research. Penalties are severe, including termination and possible action by the state against individuals.
Whatever privacy violation Google committed here is diminutive in comparison to what our government does. Ironic that I just finished perusing this: http://yro.slashdot.org/story/12/05/04/1935210/fbi-we-need-wiretap-ready-web-sites-now
If you're rooted, there are apps on the market that allow you to manage permissions. Cyanogenmod includes this capability in the ROM itself. It would be a nice feature for stock Android to have, but I doubt that will happen.
Does anyone actually know what his training or education background is? I don't think there was never any doubt that he was paid to slander open source software, but I've always wondered if he was one person or an outfit of people, and why he was so often quoted as an "expert" and "consultant" in software patent disputes. Is he a licensed attorney or software engineer, or just a journalist with an interest in this stuff?
The new HTC One V has similar hardware but the CPU is significantly underclocked compared to that of the Lumia, and ships with ICS.
Google Earth does not use wine--I don't recall that ever being the case. Download it for yourself and you'll find native linux binaries and libraries with a Qt UI. In fact, Picassa is the only Google product I know of that relies on wine.
In CT, we have the highest state tax on gasoline and among the highest in tax per capita. We probably have the most underfunded state pension fund in the country. The state enacted a tax credit last year that it can't afford, and is being blamed, in part, for the budget deficit we now have. CT has had a spending problem for years, and the answer isn't raising taxes.
This isn't necessarily true. In CT for example, I can't legally prescribe narcotic analgesics to treat heroin dependency. I can prescribe them for pain, but the patient must be in a treatment program and under the care of a physician registered for this purpose. In all other cases, when if I prescribe something off-label, I can incur liability if that patient is harmed from that medication. Lawyers will usually pursue the physician instead or in addition to the manufacturer.
No, toxicology studies are far less costly than clinical trials, which determine if a medication or medical device is efficacious. To gain a new indication on a drug, new clinical trials have to be performed to establish efficacy. Even a single study involving a few thousand patients is incredibly expensive. Also, Proscar is a 5mg dose, not 4mg.
http://www.youtube.com/watch?v=RFZrzg62Zj0
It made it in as anticipated: https://plus.google.com/112413860260589530492/posts/DDTKFhiDS9U
What version of HTML5 will Microsoft support? I thought independent HTML5 benchmarks had IE as the least compatible browser. Are we going back down this road again?
The vast majority of prescribed antipsychotics are atypicals. While they are FDA approved for schizophrenia and type I bipolar, they are also useful off-label in treating major depressive disorder, augmentation in dementia, and even for sleep disorders. The same is true of antidepressants. Tricyclics are often used to treat neuropathic disorders--usually pain, and SSRI's are used off-label for bulimia, Raynaud's, and fibromyalgia. Psychiatric medicine is perhaps the least understood of all areas of medicine. Increased utilization of medication doesn't necessarily correlate with an increase in incidence of disease or inappropriate management of therapy. Historically, this has been linked to improvements in diagnosis rates, and sometimes because the use of a medication has expanded.
I was an intern in the pharmaceutical industry and it gave me a perspective of how shady and deceitful of a business it is. However, it's one example of patents working as intended. Manufacturers can obtain patents on a drug, a novel delivery system, or a device. This doesn't impair other manufacturers from altering the molecule to produce a competing drug. That's why we have drug classes, and often the analogs differ from the progenitor by a single substitution. Consider the statins, a class of antihyperlipidemics and some of the most common drugs used in the US. The newer agents have trended towards improved potency and adverse effect profile, longer half-life, and reduced drug-drug interactions. The patents, applied for during the development phase, typically only have 5-10 years left once the drug is available on the US market, and at that point, vastly less expensive generics can be produced. Thus, patents allow drug manufacturers to recoup the cost of drug development, make a lucrative profit, while fostering innovation and encouraging the production of improved medicines. Good pharmaceuticals never reach obsolescence either; many of the more commonly prescribed meds used today were developed in the 60's, 70's, and 80's.
I believe the stock G1 was underclocked below that of the iphone, it didn't run at the spec rate.
They have a long way to go until they leave the Kuiper Belt and really reach the edge of our solar system, but impressive none the less.
The XBox is the reason that I think Microsoft has a slim chance at the smartphone market. How many companies can spend billions of US dollars on hardware subsidies over a period of years? We could see 'buy one, get one' deals for a long time to come. Or perhaps a free Windows smartphone with the purchase of a Windows laptop. Unlike Android handset manufacturers and Apple, Microsoft doesn't have to make a profit on WP7. They can lose money hand over fist, but if they are slowly increasing their marketshare, then Microsoft can declare success.
I think he meant the FTC, not the FCC.
I remember reading that Microsoft paid Nokia 1B USD to make wp7 the primary platform, but not the exclusive one. If this is true, Nokia can continue Meego and low end Symbian, and dabble in Android if necessary without breaking the deal they made. They might have to.
OpenLogic sells a product called the OLEX App Store Edition which provides tooling that can be used by developers to do a self-service scan on their apps prior to submitting to the app store and by app stores to track open source compliance.
I don't doubt that violations are occurring, but I question data when not provided by an independent third party.